Therapeutic Strategies Aimed at Improving Neuroplasticity in Alzheimer Disease
- Autores
- Colavitta, María Florencia; Barrantes, Francisco Jose
- Año de publicación
- 2023
- Idioma
- inglés
- Tipo de recurso
- artículo
- Estado
- versión publicada
- Descripción
- Alzheimer disease (AD) is the most prevalent form of dementia among elderly people. Owing to its varied and multicausal etiopathology, intervention strategies have been highly diverse. Despite ongoing advances in the field, efficient therapies to mitigate AD symptoms or delay their progression are still of limited scope. Neuroplasticity, in broad terms the ability of the brain to modify its structure in response to external stimulation or damage, has received growing attention as a possible therapeutic target, since the disruption of plastic mechanisms in the brain appear to correlate with various forms of cognitive impairment present in AD patients. Several pre-clinical and clinical studies have attempted to enhance neuroplasticity via different mechanisms, for example, regulating glucose or lipid metabolism, targeting the activity of neurotransmitter systems, or addressing neuroinflammation. In this review, we first describe several structural and functional aspects of neuroplasticity. We then focus on the current status of pharmacological approaches to AD stemming from clinical trials targeting neuroplastic mechanisms in AD patients. This is followed by an analysis of analogous pharmacological interventions in animal models, according to their mechanisms of action.
Fil: Colavitta, María Florencia. Pontificia Universidad Católica Argentina "Santa María de los Buenos Aires". Instituto de Investigaciones Biomédicas. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Houssay. Instituto de Investigaciones Biomédicas; Argentina
Fil: Barrantes, Francisco Jose. Pontificia Universidad Católica Argentina "Santa María de los Buenos Aires". Instituto de Investigaciones Biomédicas. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Houssay. Instituto de Investigaciones Biomédicas; Argentina - Materia
-
ALZHEIMER DISEASE
COGNITION
COGNITIVE IMPAIRMENT: ANIMAL MODELS
DEMENTIAS
LONG-TERM POTENTIATION
NEURODEGENERATIVE DISEASES
NEUROINFLAMMATION
NEUROPLASTICITY
NEUROTRANSMITTERS
THERAPEUTICS - Nivel de accesibilidad
- acceso abierto
- Condiciones de uso
- https://creativecommons.org/licenses/by/2.5/ar/
- Repositorio
- Institución
- Consejo Nacional de Investigaciones Científicas y Técnicas
- OAI Identificador
- oai:ri.conicet.gov.ar:11336/227770
Ver los metadatos del registro completo
id |
CONICETDig_68c921d94cdafc72d820b9a958d44200 |
---|---|
oai_identifier_str |
oai:ri.conicet.gov.ar:11336/227770 |
network_acronym_str |
CONICETDig |
repository_id_str |
3498 |
network_name_str |
CONICET Digital (CONICET) |
spelling |
Therapeutic Strategies Aimed at Improving Neuroplasticity in Alzheimer DiseaseColavitta, María FlorenciaBarrantes, Francisco JoseALZHEIMER DISEASECOGNITIONCOGNITIVE IMPAIRMENT: ANIMAL MODELSDEMENTIASLONG-TERM POTENTIATIONNEURODEGENERATIVE DISEASESNEUROINFLAMMATIONNEUROPLASTICITYNEUROTRANSMITTERSTHERAPEUTICShttps://purl.org/becyt/ford/3.3https://purl.org/becyt/ford/3Alzheimer disease (AD) is the most prevalent form of dementia among elderly people. Owing to its varied and multicausal etiopathology, intervention strategies have been highly diverse. Despite ongoing advances in the field, efficient therapies to mitigate AD symptoms or delay their progression are still of limited scope. Neuroplasticity, in broad terms the ability of the brain to modify its structure in response to external stimulation or damage, has received growing attention as a possible therapeutic target, since the disruption of plastic mechanisms in the brain appear to correlate with various forms of cognitive impairment present in AD patients. Several pre-clinical and clinical studies have attempted to enhance neuroplasticity via different mechanisms, for example, regulating glucose or lipid metabolism, targeting the activity of neurotransmitter systems, or addressing neuroinflammation. In this review, we first describe several structural and functional aspects of neuroplasticity. We then focus on the current status of pharmacological approaches to AD stemming from clinical trials targeting neuroplastic mechanisms in AD patients. This is followed by an analysis of analogous pharmacological interventions in animal models, according to their mechanisms of action.Fil: Colavitta, María Florencia. Pontificia Universidad Católica Argentina "Santa María de los Buenos Aires". Instituto de Investigaciones Biomédicas. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Houssay. Instituto de Investigaciones Biomédicas; ArgentinaFil: Barrantes, Francisco Jose. Pontificia Universidad Católica Argentina "Santa María de los Buenos Aires". Instituto de Investigaciones Biomédicas. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Houssay. Instituto de Investigaciones Biomédicas; ArgentinaMDPI2023-08info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionhttp://purl.org/coar/resource_type/c_6501info:ar-repo/semantics/articuloapplication/pdfapplication/pdfhttp://hdl.handle.net/11336/227770Colavitta, María Florencia; Barrantes, Francisco Jose; Therapeutic Strategies Aimed at Improving Neuroplasticity in Alzheimer Disease; MDPI; Pharmaceutics; 15; 8; 8-2023; 1-231999-4923CONICET DigitalCONICETenginfo:eu-repo/semantics/altIdentifier/doi/10.3390/pharmaceutics15082052info:eu-repo/semantics/openAccesshttps://creativecommons.org/licenses/by/2.5/ar/reponame:CONICET Digital (CONICET)instname:Consejo Nacional de Investigaciones Científicas y Técnicas2025-09-29T10:18:04Zoai:ri.conicet.gov.ar:11336/227770instacron:CONICETInstitucionalhttp://ri.conicet.gov.ar/Organismo científico-tecnológicoNo correspondehttp://ri.conicet.gov.ar/oai/requestdasensio@conicet.gov.ar; lcarlino@conicet.gov.arArgentinaNo correspondeNo correspondeNo correspondeopendoar:34982025-09-29 10:18:05.145CONICET Digital (CONICET) - Consejo Nacional de Investigaciones Científicas y Técnicasfalse |
dc.title.none.fl_str_mv |
Therapeutic Strategies Aimed at Improving Neuroplasticity in Alzheimer Disease |
title |
Therapeutic Strategies Aimed at Improving Neuroplasticity in Alzheimer Disease |
spellingShingle |
Therapeutic Strategies Aimed at Improving Neuroplasticity in Alzheimer Disease Colavitta, María Florencia ALZHEIMER DISEASE COGNITION COGNITIVE IMPAIRMENT: ANIMAL MODELS DEMENTIAS LONG-TERM POTENTIATION NEURODEGENERATIVE DISEASES NEUROINFLAMMATION NEUROPLASTICITY NEUROTRANSMITTERS THERAPEUTICS |
title_short |
Therapeutic Strategies Aimed at Improving Neuroplasticity in Alzheimer Disease |
title_full |
Therapeutic Strategies Aimed at Improving Neuroplasticity in Alzheimer Disease |
title_fullStr |
Therapeutic Strategies Aimed at Improving Neuroplasticity in Alzheimer Disease |
title_full_unstemmed |
Therapeutic Strategies Aimed at Improving Neuroplasticity in Alzheimer Disease |
title_sort |
Therapeutic Strategies Aimed at Improving Neuroplasticity in Alzheimer Disease |
dc.creator.none.fl_str_mv |
Colavitta, María Florencia Barrantes, Francisco Jose |
author |
Colavitta, María Florencia |
author_facet |
Colavitta, María Florencia Barrantes, Francisco Jose |
author_role |
author |
author2 |
Barrantes, Francisco Jose |
author2_role |
author |
dc.subject.none.fl_str_mv |
ALZHEIMER DISEASE COGNITION COGNITIVE IMPAIRMENT: ANIMAL MODELS DEMENTIAS LONG-TERM POTENTIATION NEURODEGENERATIVE DISEASES NEUROINFLAMMATION NEUROPLASTICITY NEUROTRANSMITTERS THERAPEUTICS |
topic |
ALZHEIMER DISEASE COGNITION COGNITIVE IMPAIRMENT: ANIMAL MODELS DEMENTIAS LONG-TERM POTENTIATION NEURODEGENERATIVE DISEASES NEUROINFLAMMATION NEUROPLASTICITY NEUROTRANSMITTERS THERAPEUTICS |
purl_subject.fl_str_mv |
https://purl.org/becyt/ford/3.3 https://purl.org/becyt/ford/3 |
dc.description.none.fl_txt_mv |
Alzheimer disease (AD) is the most prevalent form of dementia among elderly people. Owing to its varied and multicausal etiopathology, intervention strategies have been highly diverse. Despite ongoing advances in the field, efficient therapies to mitigate AD symptoms or delay their progression are still of limited scope. Neuroplasticity, in broad terms the ability of the brain to modify its structure in response to external stimulation or damage, has received growing attention as a possible therapeutic target, since the disruption of plastic mechanisms in the brain appear to correlate with various forms of cognitive impairment present in AD patients. Several pre-clinical and clinical studies have attempted to enhance neuroplasticity via different mechanisms, for example, regulating glucose or lipid metabolism, targeting the activity of neurotransmitter systems, or addressing neuroinflammation. In this review, we first describe several structural and functional aspects of neuroplasticity. We then focus on the current status of pharmacological approaches to AD stemming from clinical trials targeting neuroplastic mechanisms in AD patients. This is followed by an analysis of analogous pharmacological interventions in animal models, according to their mechanisms of action. Fil: Colavitta, María Florencia. Pontificia Universidad Católica Argentina "Santa María de los Buenos Aires". Instituto de Investigaciones Biomédicas. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Houssay. Instituto de Investigaciones Biomédicas; Argentina Fil: Barrantes, Francisco Jose. Pontificia Universidad Católica Argentina "Santa María de los Buenos Aires". Instituto de Investigaciones Biomédicas. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Houssay. Instituto de Investigaciones Biomédicas; Argentina |
description |
Alzheimer disease (AD) is the most prevalent form of dementia among elderly people. Owing to its varied and multicausal etiopathology, intervention strategies have been highly diverse. Despite ongoing advances in the field, efficient therapies to mitigate AD symptoms or delay their progression are still of limited scope. Neuroplasticity, in broad terms the ability of the brain to modify its structure in response to external stimulation or damage, has received growing attention as a possible therapeutic target, since the disruption of plastic mechanisms in the brain appear to correlate with various forms of cognitive impairment present in AD patients. Several pre-clinical and clinical studies have attempted to enhance neuroplasticity via different mechanisms, for example, regulating glucose or lipid metabolism, targeting the activity of neurotransmitter systems, or addressing neuroinflammation. In this review, we first describe several structural and functional aspects of neuroplasticity. We then focus on the current status of pharmacological approaches to AD stemming from clinical trials targeting neuroplastic mechanisms in AD patients. This is followed by an analysis of analogous pharmacological interventions in animal models, according to their mechanisms of action. |
publishDate |
2023 |
dc.date.none.fl_str_mv |
2023-08 |
dc.type.none.fl_str_mv |
info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion http://purl.org/coar/resource_type/c_6501 info:ar-repo/semantics/articulo |
format |
article |
status_str |
publishedVersion |
dc.identifier.none.fl_str_mv |
http://hdl.handle.net/11336/227770 Colavitta, María Florencia; Barrantes, Francisco Jose; Therapeutic Strategies Aimed at Improving Neuroplasticity in Alzheimer Disease; MDPI; Pharmaceutics; 15; 8; 8-2023; 1-23 1999-4923 CONICET Digital CONICET |
url |
http://hdl.handle.net/11336/227770 |
identifier_str_mv |
Colavitta, María Florencia; Barrantes, Francisco Jose; Therapeutic Strategies Aimed at Improving Neuroplasticity in Alzheimer Disease; MDPI; Pharmaceutics; 15; 8; 8-2023; 1-23 1999-4923 CONICET Digital CONICET |
dc.language.none.fl_str_mv |
eng |
language |
eng |
dc.relation.none.fl_str_mv |
info:eu-repo/semantics/altIdentifier/doi/10.3390/pharmaceutics15082052 |
dc.rights.none.fl_str_mv |
info:eu-repo/semantics/openAccess https://creativecommons.org/licenses/by/2.5/ar/ |
eu_rights_str_mv |
openAccess |
rights_invalid_str_mv |
https://creativecommons.org/licenses/by/2.5/ar/ |
dc.format.none.fl_str_mv |
application/pdf application/pdf |
dc.publisher.none.fl_str_mv |
MDPI |
publisher.none.fl_str_mv |
MDPI |
dc.source.none.fl_str_mv |
reponame:CONICET Digital (CONICET) instname:Consejo Nacional de Investigaciones Científicas y Técnicas |
reponame_str |
CONICET Digital (CONICET) |
collection |
CONICET Digital (CONICET) |
instname_str |
Consejo Nacional de Investigaciones Científicas y Técnicas |
repository.name.fl_str_mv |
CONICET Digital (CONICET) - Consejo Nacional de Investigaciones Científicas y Técnicas |
repository.mail.fl_str_mv |
dasensio@conicet.gov.ar; lcarlino@conicet.gov.ar |
_version_ |
1844614139742257152 |
score |
13.070432 |